| Date Filed | Type | Description |
| 05/25/2023 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Sold 9,000 shares
@ $4.05, valued at
$36.5k
Exercised 9,000 options
@ $3.68, valued at
$33.1k
|
|
| 05/23/2023 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Sold 1,000 shares
@ $4.05, valued at
$4.1k
Exercised 1,000 options
@ $3.68, valued at
$3.7k
|
|
| 05/19/2023 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Sold 50,000 shares
@ $3.89, valued at
$194.5k
Exercised 50,000 options
@ $3.68, valued at
$184k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 5,289 shares
@ $66.29, valued at
$350.6k
|
|
| 12/20/2022 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $61.8657, valued at
$618.7k
|
|
| 12/14/2022 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Disposed/sold 3,944 shares
@ $64.8, valued at
$255.6k
Exercised 20,000 options to buy
@ $12.78, valued at
$255.6k
|
|
| 12/01/2022 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,803 shares
@ $72.9, valued at
$714.6k
|
|
| 11/21/2022 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $78.3173, valued at
$783.2k
Exercised 10,000 options to buy
@ $12.78, valued at
$127.8k
|
|
| 11/07/2022 |
4/A
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/22/2022 |
4/A
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $88.06, valued at
$88.1k
|
|
| 09/16/2022 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $90, valued at
$180k
Sold 3,000 shares
@ $89.35, valued at
$268.1k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,946 shares
@ $123.68, valued at
$240.7k
Paid exercise price by delivering 2,061 shares
@ $123.68, valued at
$254.9k
Paid exercise price by delivering 1,916 shares
@ $123.68, valued at
$237k
|
|
| 01/28/2022 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 9,606 shares
@ $0
Granted 13,560 shares
@ $0
Paid exercise price by delivering 3,060 shares
@ $113.68, valued at
$347.9k
Paid exercise price by delivering 6,183 shares
@ $113.68, valued at
$702.9k
|
|
| 11/12/2021 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $160.5, valued at
$481.5k
|
|
| 11/01/2021 |
4
| HIGGINS JOHN L (Director) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 194 shares
@ $0
Granted 633 options to buy
@ $515.24, valued at
$326.1k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 50,000 shares
@ $159, valued at
$8M
Granted 5,946 shares
@ $0
Paid exercise price by delivering 2,845 shares
@ $156.01, valued at
$443.8k
Granted 9,607 shares
@ $0
Paid exercise price by delivering 4,596 shares
@ $156.01, valued at
$717k
Sold 40,000 shares
@ $182, valued at
$7.3M
Exercised 50,000 options to buy
@ $14.47, valued at
$723.5k
Exercised 40,000 options to buy
@ $14.47, valued at
$578.8k
Exercised 30,000 options to buy
@ $21.92, valued at
$657.6k
|
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,683 shares
@ $87.52, valued at
$147.3k
Exercised 14,657 options to buy
@ $10.05, valued at
$147.3k
|
|
| 11/10/2020 |
4
| HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,458 shares
@ $81.77, valued at
$201k
Exercised 20,000 options to buy
@ $10.05, valued at
$201k
|
|
|